{"id":359,"date":"1997-03-01T12:02:00","date_gmt":"1997-03-01T11:02:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/1997\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt"},"modified":"1997-03-01T12:02:00","modified_gmt":"1997-03-01T11:02:00","slug":"sekundaere-prophylaxe-nach-akutem-myokardinfarkt","status":"publish","type":"post","link":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\/","title":{"rendered":"Sekund\u00e4re Prophylaxe nach akutem Myokardinfarkt"},"content":{"rendered":"<p>Nach einem Myokardinfarkt oder anderen Erkrankungen, die als Komplikationen der Arteriosklerose anzusehen sind, geht es darum, die betroffenen Patienten davon zu \u00fcberzeugen, da\u00df sie nicht rauchen d\u00fcrfen, da\u00df ihre Blutfette gesenkt werden m\u00fcssen, da\u00df sie ein k\u00f6rperlich aktives Leben f\u00fchren sollen, da\u00df der Blutdruck normale Werte haben soll und da\u00df sie auf die Einnahme von [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Nach einem Myokardinfarkt oder anderen Erkrankungen, die als Komplikationen der Arteriosklerose anzusehen sind, geht es darum, die betroffenen Patienten davon zu \u00fcberzeugen, da\u00df sie nicht rauchen d\u00fcrfen, da\u00df ihre Blutfette gesenkt werden m\u00fcssen, da\u00df sie ein k\u00f6rperlich aktives Leben f\u00fchren sollen, da\u00df der Blutdruck normale Werte haben soll und da\u00df sie auf die Einnahme von [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","footnotes":""},"categories":[1],"tags":[954,1806,605,81,80,82,78,2285,5620,251,74,6003],"class_list":["post-359","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-ace-hemmer","tag-amiodaron","tag-antiarrhythmika","tag-beta-blocker","tag-betablocker","tag-betarezeptoren-blocker","tag-herzinfarkt","tag-kalziumantagonisten","tag-lidocain","tag-magnesium","tag-myokardinfarkt","tag-nitrate"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sekund\u00e4re Prophylaxe nach akutem Myokardinfarkt - Der Arzneimittelbrief<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sekund\u00e4re Prophylaxe nach akutem Myokardinfarkt - Der Arzneimittelbrief\" \/>\n<meta property=\"og:description\" content=\"Nach einem Myokardinfarkt oder anderen Erkrankungen, die als Komplikationen der Arteriosklerose anzusehen sind, geht es darum, die betroffenen Patienten davon zu \u00fcberzeugen, da\u00df sie nicht rauchen d\u00fcrfen, da\u00df ihre Blutfette gesenkt werden m\u00fcssen, da\u00df sie ein k\u00f6rperlich aktives Leben f\u00fchren sollen, da\u00df der Blutdruck normale Werte haben soll und da\u00df sie auf die Einnahme von [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\/\" \/>\n<meta property=\"og:site_name\" content=\"Der Arzneimittelbrief\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/derarzneimittelbrief.de\" \/>\n<meta property=\"article:published_time\" content=\"1997-03-01T11:02:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/1997\/03\/Abbildung-1997-20-1.gif\" \/>\n<meta name=\"author\" content=\"Dennis Hoppe\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dennis Hoppe\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"2\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\\\/\"},\"author\":{\"name\":\"Dennis Hoppe\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/a04aadd6db7c06c7464bdbbb5396ed16\"},\"headline\":\"Sekund\u00e4re Prophylaxe nach akutem Myokardinfarkt\",\"datePublished\":\"1997-03-01T11:02:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\\\/\"},\"wordCount\":318,\"image\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/1997\\\/03\\\/Abbildung-1997-20-1.gif\",\"keywords\":[\"ACE-Hemmer\",\"Amiodaron\",\"Antiarrhythmika\",\"Beta-Blocker\",\"Betablocker\",\"Betarezeptoren-Blocker\",\"Herzinfarkt\",\"Kalziumantagonisten\",\"Lidocain\",\"Magnesium\",\"Myokardinfarkt\",\"Nitrate\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\\\/\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\\\/\",\"name\":\"Sekund\u00e4re Prophylaxe nach akutem Myokardinfarkt - Der Arzneimittelbrief\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/1997\\\/03\\\/Abbildung-1997-20-1.gif\",\"datePublished\":\"1997-03-01T11:02:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/a04aadd6db7c06c7464bdbbb5396ed16\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/1997\\\/03\\\/Abbildung-1997-20-1.gif\",\"contentUrl\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/1997\\\/03\\\/Abbildung-1997-20-1.gif\",\"width\":500,\"height\":319},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Start\",\"item\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sekund\u00e4re Prophylaxe nach akutem Myokardinfarkt\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#website\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/\",\"name\":\"Der Arzneimittelbrief\",\"description\":\"Unabh\u00e4ngige Arzneimittelinformationen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/a04aadd6db7c06c7464bdbbb5396ed16\",\"name\":\"Dennis Hoppe\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g\",\"caption\":\"Dennis Hoppe\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sekund\u00e4re Prophylaxe nach akutem Myokardinfarkt - Der Arzneimittelbrief","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\/","og_locale":"de_DE","og_type":"article","og_title":"Sekund\u00e4re Prophylaxe nach akutem Myokardinfarkt - Der Arzneimittelbrief","og_description":"Nach einem Myokardinfarkt oder anderen Erkrankungen, die als Komplikationen der Arteriosklerose anzusehen sind, geht es darum, die betroffenen Patienten davon zu \u00fcberzeugen, da\u00df sie nicht rauchen d\u00fcrfen, da\u00df ihre Blutfette gesenkt werden m\u00fcssen, da\u00df sie ein k\u00f6rperlich aktives Leben f\u00fchren sollen, da\u00df der Blutdruck normale Werte haben soll und da\u00df sie auf die Einnahme von [&hellip;]","og_url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\/","og_site_name":"Der Arzneimittelbrief","article_publisher":"http:\/\/www.facebook.com\/derarzneimittelbrief.de","article_published_time":"1997-03-01T11:02:00+00:00","og_image":[{"url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/1997\/03\/Abbildung-1997-20-1.gif","type":"","width":"","height":""}],"author":"Dennis Hoppe","twitter_misc":{"Verfasst von":"Dennis Hoppe","Gesch\u00e4tzte Lesezeit":"2\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\/#article","isPartOf":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\/"},"author":{"name":"Dennis Hoppe","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/a04aadd6db7c06c7464bdbbb5396ed16"},"headline":"Sekund\u00e4re Prophylaxe nach akutem Myokardinfarkt","datePublished":"1997-03-01T11:02:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\/"},"wordCount":318,"image":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\/#primaryimage"},"thumbnailUrl":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/1997\/03\/Abbildung-1997-20-1.gif","keywords":["ACE-Hemmer","Amiodaron","Antiarrhythmika","Beta-Blocker","Betablocker","Betarezeptoren-Blocker","Herzinfarkt","Kalziumantagonisten","Lidocain","Magnesium","Myokardinfarkt","Nitrate"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\/","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\/","name":"Sekund\u00e4re Prophylaxe nach akutem Myokardinfarkt - Der Arzneimittelbrief","isPartOf":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\/#primaryimage"},"image":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\/#primaryimage"},"thumbnailUrl":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/1997\/03\/Abbildung-1997-20-1.gif","datePublished":"1997-03-01T11:02:00+00:00","author":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/a04aadd6db7c06c7464bdbbb5396ed16"},"breadcrumb":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\/#primaryimage","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/1997\/03\/Abbildung-1997-20-1.gif","contentUrl":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/1997\/03\/Abbildung-1997-20-1.gif","width":500,"height":319},{"@type":"BreadcrumbList","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/sekundaere-prophylaxe-nach-akutem-myokardinfarkt\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Start","item":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/"},{"@type":"ListItem","position":2,"name":"Sekund\u00e4re Prophylaxe nach akutem Myokardinfarkt"}]},{"@type":"WebSite","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#website","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/","name":"Der Arzneimittelbrief","description":"Unabh\u00e4ngige Arzneimittelinformationen","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/a04aadd6db7c06c7464bdbbb5396ed16","name":"Dennis Hoppe","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g","caption":"Dennis Hoppe"}}]}},"_links":{"self":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/359","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/comments?post=359"}],"version-history":[{"count":0,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/359\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/media?parent=359"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/categories?post=359"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/tags?post=359"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}